Ali Guermazi (Ed.)

2006

Until recently, surgical resection was considered the only option for treatment of kidney cancer, especially renal cell carcinoma. The disease is relatively resistant to both radiotherapy and chemotherapy, and although alternative systemic therapies such as interleukin- 2 immunotherapy and interferon have shown promise, objective response rates are still quite low.